Vice President of Portfolio & Programs at Danaher Corporation

Deer Park, Illinois, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Life Sciences, Diagnostics, Biotechnology, Cancer DiagnosticsIndustries

Requirements

Visionary and results-driven senior thought leader capable of shaping long-term product portfolio and driving strategic program excellence
Deep market insight, competitive intelligence, and customer engagement skills to guide high-ROI decisions
Experience in architecting 3- to 10-year roadmaps for diagnostics portfolios based on clinical utility, health economic outcomes, unmet market needs, and scientific innovation
Ability to thrive in a dynamic, high-performing environment at the intersection of strategy, innovation, and execution
High visibility and influence to work closely with commercial and cross-functional leaders (R&D, Operations, Regulatory, Commercial)
Preferred onsite location: Deer Park, IL (USA)

Responsibilities

Define and maintain a multi-year strategic portfolio roadmap based on clinical utility, health economic outcomes, unmet market needs, and scientific innovation
Drive portfolio prioritization to fuel revenue growth and market leadership
Oversee all cross-functional program execution, leveraging new efficiency tools/AI as needed, to ensure timely delivery of differentiated products
Partner with R&D, Operations, Regulatory, and Commercial to optimize program velocity, ROI, and value creation
Deliver consistent year-over-year double-digit revenue growth across key business segments
Personally lead critical programs aligning with the business unit’s growth vision, including new product introductions, transformative partnerships, and platform extensions (e.g., AI-driven diagnostics, novel biomarkers, multiplexing, spatial)
Define and prioritize investment areas
Ensure timely delivery of high-impact solutions
Translate strategy into market success and drive sustained revenue growth, share gains, and enhanced clinical impact in digital pathology and precision oncology

Skills

Portfolio Management

Program Management

Strategic Planning

Product Innovation

Revenue Growth

Leadership

Business Strategy

Execution

Danaher Corporation

Water quality, diagnostics, and identification solutions

About Danaher Corporation

Danaher Corporation operates in key markets such as water quality, product identification, and diagnostics. The company provides precision instruments and advanced purification technologies for analyzing and managing water, ensuring its safety in various environments. In product identification, Danaher specializes in laser marking, coding, and packaging solutions that help maintain product freshness and accurate labeling throughout the supply chain. In the diagnostics sector, Danaher offers tools and software that enhance diagnostic confidence, enabling healthcare providers to deliver effective care. What sets Danaher apart from competitors is its unique Danaher Business System, which focuses on continuous improvement and empowers employees to drive change. The company's goal is to consistently deliver high-performance products and solutions while maintaining leadership in its markets.

Washington, District of ColumbiaHeadquarters

1969Year Founded

IPOCompany Stage

Industrial & Manufacturing, Healthcare, Consumer GoodsIndustries

10,001+Employees

Risks

Increased competition from Roche and Abbott in AI-driven diagnostics.

Potential regulatory challenges in the EU for water quality sector.

Supply chain vulnerabilities affecting precision instruments sourcing.

Differentiation

Danaher's Danaher Business System drives continuous improvement and superior financial performance.

The acquisition of Cytiva enhances Danaher's capabilities in the biopharmaceutical sector.

Danaher's advanced purification technologies meet increasing demands for sustainable water management.

Upsides

Danaher's investment in AI-driven healthcare solutions boosts its diagnostics capabilities.

Cytiva acquisition expands Danaher's market share in the biopharmaceutical sector.

Point-of-care testing demand drives growth for Danaher's diagnostic tools and software.

Land your dream remote job 3x faster with AI

Try Jobo Free